- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Participation in OCM May Transform Care for Certain Cancer Types More Quickly Than Others
Physicians participating in the Oncology Care Model now provider care for approximately 21% of Medicare patients with cancer. An analysis from Avalere Health found that those doctors treat some types of cancers more than others.
Approximately 21% of Medicare patients with cancer are now receiving care from a physician participating in the Oncology Care Model (OCM), but with representation of cancer types varying, trends of participation in OCM could actually skew the transformation of cancer treatment more heavily for some cancers, according to Avalere Health.
A new report found that breast and lung cancers were the more common types of cancers with more than 25% of patients with breast and lung cancers treated by a doctor participating in the OCM.
Participation in the OCM has led oncologists to reshape their practices in order to deliver higher quality care at a lower cost, explained Dana Macher, vice president at Avalere. She added that the OCM has the potential to redefine care for all patients with oncology. However, the transformation of care may happen faster for some cancer types as a result of which patients are being cared for under OCM.
“About one-fifth of Medicare Part B fee-for-service patients are treated by a doctor participating in the Oncology Care Model, but those doctors are treating more of some cancer types than others,” Richard Kane, senior director at Avalere, said in a statement. “The Oncology Care Model may be accelerating oncology practice transformation for some cancers more than others.”
The OCM is a 5-year alternative payment model pilot that aligns financial incentives with care coordination, appropriateness of care, and access to care for beneficiaries receiving chemotherapy. The model has 2 forms of payment: a monthly enhanced oncology service payment for 21 cancers and a group of less common cancer types and the potential for performance-based payments for those 21 cancers.
Avalere estimates that a total of 2.2 million patients in Medicare Part B fee-for-service had the types of cancer covered in OCM. Of those patients 472,000 (21%) were receiving care from a doctor participating in OCM.
More than half of all patients being treated under the OCM have breast, prostate, lung, or small intestine/colon cancers, or lymphoma, according to the Avalere analysis.
The American Journal of Managed Care® will be hosting a webcast with experts to discuss practical experiences, challenges, and successes from within the OCM on June 28 at noon, 3 pm, and 6 pm EST. Learn more about the webcast.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
